Exploratory evaluation of surrogate markers of cardiovascular risk in patients with active chronic plaque-type psoriasis

Update Il y a 4 ans
Reference: EUCTR2013-002266-40

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate flow mediated dilation (FMD) by Doppler ultrasound at week 12 in subjects in treatment arm A (300 mg Secukinumab) compared to the pooled group of patients in treatment arms C and D (placebo up to week 12).


Inclusion criteria

  • active chronic plaque-type psoriasis

Links